Why do women with early RA respond less well to MTX than men? Gender as a determinant of clinical response in the initial open-label phase of the SWEFOT clinical trial

R. F. van Vollenhoven,S. Emestam,L. Coster, C. Dackhammar,K. Forslind,P. Geborek,H. Hellstrom,L. Ljung, R. Oding, I. F. Petersson,A. Teleman,J. Theander, A. Thorner, B. Tornqvist, E. Waltbrand,A. Zickert, M. Wornert,J. Bratt

ANNALS OF THE RHEUMATIC DISEASES(2007)

Cited 0|Views15
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined